Gut microbiota‐derived synbiotic formula (SIM01) as a novel

Frontiers The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

Synbiotic may lower risk of Covid complications in vulnerable

Nutrients, Free Full-Text

A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases

IJMS, Free Full-Text

Can a microbiota-derived health supplement mitigate adverse events after COVID-19 vaccination in children?

Viruses, Free Full-Text

Dextrin, C18H32O16

IJMS, Free Full-Text

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Introduction to host microbiome symbiosis in health and disease

Synbiotic formula shows promise in reducing long COVID symptoms

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Full article: A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination